Diabetes has evolved as one of the primary healthcare epidemic characterized by high sugar levels and principle cause of mortality worldwide. In 2014, World Health Organization (WHO) estimated 8.5% of adults living with diabetes. A diabetic person cannot either synthesize enough insulin (type 1 diabetes) or either does not make enough insulin or cannot effectively use the insulin produced by the body (type 2 diabetes). Another type of diabetes that occur in women during her pregnancy is gestational diabetes. However, gestational diabetes is usually resolved after delivery but can precede towards type 2 diabetes later in a women’s life. Most of the continuous glucose monitoring devices are invasive and involves use of needles leading to increased chance of infection. Furthermore, the invasive glucose monitoring device is considered to be discrete glucose measurement system which cannot be practically used for continuous monitoring of blood glucose. Certain evidences of hyperglycemia between measurements are however not recorded thus resulting in false or no representation of the blood glucose pattern. Noninvasive monitoring of glucose levels eliminates the need of painful pricking with increased risk of infection, and amount of damage caused to the finger tissue.
Therefore, non-invasive continuous glucose monitoring devices are being widely investigated and studied over the past few years for their ability to monitor glucose continuously under highly controlled (e.g. in-clinic) conditions. Various techniques that involves measurement of blood glucose levels non-invasively includes, Near Infrared Spectroscopy (NIRS), Mid -Infrared Spectroscopy (Mid-IRS), Raman Spectroscopy, Photo-acoustic Spectroscopy (PA), Optical Coherence Tomography (OCT) and many more.
Non- Invasive Blood Glucose Monitoring DevicesMarket: Drivers & Restraints
Rising prevalence of diabetes globally is expected to result in greater use of noninvasive blood glucose monitoring devices among the prevalent population. Owing to the several disadvantages imposed by the use of invasive blood glucose monitors and growing need to develop noninvasive glucose monitoring diagnostic techniques, the market for non- invasive blood glucose monitoring devices is expected to rise at a greater pace during the forecast period. For instance, in June 2015, researchers in U.K. developed blood glucose device that utilizes low-powered lasers in order to measure the blood glucose levels on the skin surface. Also a bench-top version of the system is currently in clinical trials studies which might land in the market over the next few years. This includes, a finger-touch device similar to a computer mouse and a wearable version for continuous blood glucose monitoring. In addition, increasing efforts by several startup manufacturers, for example, Prediktor Medical- a Norway based manufacturer is developing a wearable device for estimation of blood glucose levels based on the combination of several principles determining the noninvasive glucose monitoring including, advanced multivariate analysis and dynamic models for insulin or glucose interaction. The device is expected to be in the form of a watch or bracelet communicating with the mobile phone or a tablet for data presentation. This would enable patient’s monitor their glucose levels continuously without the need for an implant. Currently available blood glucose measuring devices lacks specificity and sensitivity due to the substantial physical and chemical interference. Non-invasive glucose monitoring devices use multivariate regression analyses converting optical signal to glucose concentration. Hence the device should be designed in such a way that it leads to accurate detection of blood glucose levels imperative for optimum therapy and disease management.
Request For Report Sample: http://www.futuremarketinsights.com/reports/sample/rep-gb-2613
Non- Invasive Blood Glucose Monitoring Devices Market: Segmentation
Non- invasive blood glucose monitoring devices marketis segmented by technology, modality end user and geography:
- By Technology
- MIR/NIR (Mid/Near Infrared Spectroscopy)
- Raman Spectroscopy
- Occlusion Spectroscopy
- Optical Coherence Tomography
- Thermal Emission Spectroscopy
- Photoacoustic Spectroscopy
- Impedance/Dielectric Spectroscopy
- By Modality
- Wearable Blood Glucose Monitoring Systems
- Non-wearable /Table top Blood Glucose Monitoring Systems
- By End User
- Home Care Settings
Non- Invasive Blood Glucose Monitoring Devices Market: Overview
Rising prevalence of diabetes worldwide imposes significant economic consequences on the individual’s life. Currently, there are 350 million people worldwide estimated to live with diabetes. Thus continuous monitoring of blood glucose levels is essential in order to manage the ever increasing prevalent population living with diabetes currently. For this reason manufacturers are focusing on developing diagnostic techniques that are highly reliable and monitors individual’s blood glucose levels with greater accuracy with the capability to improve glycemic control and patient wellbeing. By integration of sensing elements, electronics along with a reliable power source in a single unit, noninvasive blood glucose monitors are offering immense opportunity for all the device manufacturers along with patients and various healthcare providers across the world. Accelerated regulatory approvals of blood glucose monitors is one of the another important factor leading to increased revenues of noninvasive blood glucose devices over the forecast period.
Request For TOC: http://www.futuremarketinsights.com/toc/rep-gb-2613
Non- Invasive Blood Glucose Monitoring Devices Market: Region-wise Outlook
On the basis of region presence, Non- Invasive Blood Glucose Monitoring Devices market is segmented into seven key regions: North America, Latin America, and Eastern Europe, Western Europe, and Asia pacific excluding japan, Japan, Middle East and Africa. Growing number of diabetic population in U.S. is the leading factor contributing towards higher adoption of noninvasive blood glucose monitoring systems. Center of Diseases Control and Prevention estimated 29.1 million of U.S. population with diabetes in the U.S. The data also estimated adult population with diabetes are at 50% higher risk of death. Furthermore, growing need of continuous non-invasive method of blood glucose diagnosis among patients is expected to create higher demand for noninvasive blood glucose monitoring systems worldwide. The incidence of diabetes is higher in regions such as Asia Pacific, North America and Western Europe. Presence of several pipeline blood glucose monitoring systems and their expected launch is expected to drive the market for noninvasive blood glucose devices over the forecast period.
Non- Invasive Blood Glucose Monitoring Devices Market: Key Players
Some of the key market players in the non- invasive blood glucose monitoring devices market are, Abbott, Animas Technologies, Bayer Healthcare, Cercacor, Pendragon Medical, OrSense, and Bayer Healthcare.
This post has been seen 165 times.